Ignyta's Series B - II Round

Ignyta raised a round of funding on January 03, 2013.

Ignyta, formerly NexDx, specializes in precision medicine and biotechnology, with an integrated Rx/Dx approach in oncology, for the benefit of cancer patients everywhere.…

Articles about Ignyta's Series B - II Round: